BioCentury
ARTICLE | Clinical News

Exparel bupivacaine regulatory update

July 18, 2016 7:00 AM UTC

FDA posted a notice on its Adverse Event Reporting System (AERS) that the agency is evaluating the need for regulatory action for pain drug Exparel bupivacaine from Pacira related to local anesthetic ...